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To illuminate the molecular basis for host range restriction of parainfluenza virus replication, we have examined the types
of virus macromolecules produced during abortive infection of nonpermissive MDBK cells with human parainfluenza virus
type 1 (hPIV1). While these cells do not support production of hPIV1 virus, they can be infected by hPIV1 as evidenced by
accumulation of intracellular viral NP and HN proteins. HPIV1 is also able to drive transcription of a synthetic analog of
Sendai virus (SV) genome RNA transfected into virus-infected MDBK cells. In contrast to transcription, hPIV1 genome
replication does not occur in MDBK cells. Intracellular full-length genome RNA was detected only in trace amounts 2 days
after infection, and was undetectable 4 days after infection. Full-length antigenome (/) sense RNA was not detectable.
Nucleocapsid complexes failed to accumulate in the cytoplasm of nonpermissive cells, and no detectable nucleocapsids
were released into the medium as virus particles. The data indicate that defective vRNA synthesis and/or nucleocapsid
formation is responsible for the inability of hPIV1 to grow in MDBK cells. Our data also show that hPIV1 is capable of
providing all helper functions for packaging SV synthetic genome analogs into infectious particles, but these SV-specific
RNAs encapsidated with hPIV1 proteins are in turn not replicated by SV proteins. These results suggest that functional
protein–protein interactions between parainfluenza virus strains have more stringent requirements than do protein–RNA
interactions. q 1996 Academic Press, Inc.
INTRODUCTION Power et al., 1992a,b), with a lower level of 53% identity
between the P proteins (Power et al., 1992a). There is
An important route to understanding the interaction of evidence that hPIV1 proteins can functionally substitute
a virus with its host is to examine what makes a particular for SV proteins in RNA replication (Curran and Kolakof-
cell permissive or nonpermissive for virus replication. sky, 1991) and that P proteins of either virus can specifi-
The ability to productively infect only a limited number cally bind to nucleocapsid cores of the other virus (Ryan
of host species is a feature shared by many viruses. The and Power, 1994). Despite their highly related proteins
molecular basis of such restricted host range involves and tropism for similar tissues, infections by SV and
the most fundamental aspects of the virus–host interac- hPIV1 are sharply restricted to different animal hosts (ro-
tion. Examining steps in the virus replication cycle which dents and humans, respectively) (Kingsbury, 1990). This
are blocked due to host range restriction may indicate host range restriction is mirrored to some extent in the
cell components required for virus growth and can help ability to replicate in cultured cells: SV can replicate in
to shed light on how the virus usurps cellular metabolic several cell lines, and in embryonated eggs, which do
processes. not support hPIV1 replication (unpublished observa-
Our laboratory studies the molecular biology of parain- tions).
fluenza virus replication, working principally with the In this work we have examined the molecular basis
closely related strains Sendai virus (SV) and human para- for the inability of hPIV1 to replicate in cultured MDBK
influenza type 1 virus (hPIV1). The close genetic relat- cells which are permissive for SV replication. Our results
edness of these two viruses is reflected in the high de- indicate that although viral transcription can occur, the
gree of amino acid identity shared by their proteins. Most multiplication of nucleocapsid complexes is defective:
proteins of hPIV1 have 68 to 87% of their amino acid vRNA is detectable only in trace amounts, (/) sense
sequence identical to the homologous SV protein (Mer- antigenome RNA is not detectable, and nucleocapsid
son et al., 1988; Gorman et al., 1990; Lyn et al., 1991; complexes are not detectable in infected cells. We have
also examined the ability of hPIV1 proteins to replicate
SV-specific genome analog RNA. Helper hPIV1 can res-1 Part of this work was presented at the 14th annual meeting of the
cue SV-specific RNA in cells permissive for both viruses,American Society for Virology, Austin, TX, July 1995.
evidenced both by efficient hPIV1-dependent intracellular2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (901) 523-2622. E-mail: kevin.ryan@stjude.org. reporter gene expression and by packaging of SV ge-
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nome analogs into infectious material. However, such and dried. Radiolabeled proteins were visualized by fluo-
rography.hybrid nucleocapsids consisting of SV-specific RNA and
hPIV1 proteins were not able to be replicated by helper Intracellular (0) sense vRNA was detected by Northern
blotting. Infection was monitored by HA assay, and cellsSV. This evidence of functional interaction between virus
strains at the protein–RNA level, but not at the protein – were harvested 2 days after infection when HA titers
were 9 to 27 for SV-infected cells and 9 for hPIV1-infectedprotein level, implies a greater flexibility in the functional
interactions of nucleocapsid proteins with vRNA than is LLC-MK2 cells (no HA was detected in hPIV1-infected
MDBK cells). Cytoplasmic RNA was extracted as de-possible with interstrain interactions among nucleocap-
sid proteins themselves. scribed (Gilman, 1991): cells were lysed with NP-40, and
cytoplasmic extracts were digested with proteinase K/
SDS and extracted with acidic phenol and chloroform.MATERIALS AND METHODS
The RNA mixture was ethanol precipitated and fraction-
Cells and viruses ated in 1% agarose gels containing 3.7 M formaldehyde
as described (Brown, 1993). RNA was blotted onto nitro-LLC-MK2 (rhesus monkey kidney) cells and MDBK (bo-
cellulose filters, and filters were hybridized with 32P-la-vine kidney) cells were grown in Dulbecco’s modified
beled probe RNA generated by in vitro T7 RNA polymer-Eagle (DME) medium supplemented with 10% fetal calf
ase synthesis of (/) sense transcripts of both the hPIV1serum (FCS) and gentamycin. Stocks of SV (Enders
and SV NP genes (Ryan et al., 1993). This (/) sense probestrain) or hPIV1 (strain C35) were grown in LLC-MK2 in
mixture hybridizes only with (0) sense vRNA molecules.DME containing 0.03% bovine serum albumin (BSA) and
Hybridized bands were detected by autoradiography.2 mg/ml acetylated trypsin. SV stocks were grown at 377;
Intracellular (/) sense viral RNA species were de-hPIV1 stocks were grown at 337. For all subsequent infec-
tected by similar Northern blot procedures. The probestions cells were incubated in DME with 0.03% BSA at 377
for these blots were generated by in vitro T7 transcriptionafter infection. When used, acetylated trypsin was added
of reverse-sense copies of the hPIV1 NP and HN genes.at 0.5 mg/ml.
These probes detected both (/) sense full-length anti-
genome replicative intermediates and specific mRNADetection of virus protein and RNA
transcripts.
Western blotting was used to detect intracellular pro-
Sendai virus genome RNA analogteins. Infected cells were washed with PBS-A (135 mM
NaCl, 3 mM KCl, 80 mM Na2HPO4 , 15 mM KH2PO4 , pH Plasmid pSend-CAT (Park et al., 1991) was provided
7.4), harvested, and lysed by direct addition of protein
by M. Krystal and used to express reporter RNA with SV-
gel loading buffer containing 2% SDS and 140 mM b-
specific sequences at its 3* and 5* termini. The plasmid
mercaptoethanol. Lysates were boiled, fractionated in
is designed so that CAT enzyme activity is expressed
7.5% polyacrylamide–SDS gels, and electroblotted onto
only when virus-specific proteins encapsidate the (0)
nitrocellulose. Monoclonal antibodies P27 and P40 were
sense SV-CAT reporter RNA and transcribe CAT mRNA
mixed for nucleoprotein detection, and monoclonal anti-
from it. Plasmid DNA was linearized with EarI prior to in
body M9 was used to detect HN protein. Protein bands
vitro transcription with T7 RNA polymerase (New England
were located by using a 125I-labeled second antibody
Biolabs). DNA template was removed by digestion with
(Amersham) and autoradiography.
RNAse-free DNAse I (Life Technologies) and RNA was
To monitor accumulation of virus nucleocapsids, in-
extracted with phenol/chloroform (1:1) and precipitated
fected cells were continuously radiolabeled with 50 mCi/
by the addition of NaCl to 200 mM and 2.5 vol of ethanol.
ml [3H]leucine in leucine-free medium. Culture medium
RNA pellets were dissolved in diethyl pyrocarbonate-
was collected and clarified by centrifugation at 12,000 g
treated H2O and stored at 0707.for 10 min. Virus was pelleted from the culture medium
supernate by centrifugation through a cushion of 25% RNA analog rescue
glycerol in PBS-A at 270,000 g for 90 min. Intracellular
nucleocapsids were prepared as previously described SV-CAT RNA was transfected into freshly confluent cell
monolayers in six-well dishes. Cells were washed with(Deshpande and Portner, 1984). Cells were lysed by
Dounce homogenization, and nucleocapsids were pel- serum-free DME and fed 2 ml/well of PBS-A containing
0.1 mg/ml gelatin (Bio-Rad), 0.3 mg/ml diethyl aminoethylleted from lysates through 50% (v/v) glycerol in D2O con-
taining 30 mM NaCl and 10 mM Tris, pH 7.6 (r  1.18 dextran (Promega), and 0.5% dimethyl sulfoxide (Sigma).
After 30 min at room temperature this solution was re-g/ml) at 260,000 g for 90 min. Pelleted virus or nucleocap-
sids were dissolved directly in protein gel loading buffer moved and replaced with an inoculum of 0.25 ml PBS-A
containing 0.1 mg/ml gelatin and 5–7 mg SV-CAT RNA.containing 2% SDS and 140 mM b-mercaptoethanol,
boiled, and fractionated in a 7.5% polyacrylamide–SDS After 60 min at room temperature the RNA inoculum was
removed and cells were infected with helper virus at agel. Gels were acid-fixed, soaked in 1 M Na-salicylate,
AID VY 7907 / 6a17$$$282 04-30-96 22:15:19 vira AP: Virology
71PARAINFLUENZA VIRUS HOST RANGE RESTRICTION
multiplicity of 5 plaque-forming units per cell. Virus was
absorbed to cells for 60 min at room temperature and
cells were then fed 2 ml/well DME containing 0.03% BSA.
Cells were incubated for 2 days at 377. Virus-containing
medium was collected and cellular debris was removed
by centrifugation at 3000 g. Prior to reinfecting fresh cells,
virus-containing supernates were treated with 2 mg/ml
acetylated trypsin for 2 hr at room temperature. Packag-
ing of SV-CAT RNA into infectious particles by hPIV1 was
confirmed by treating virus supernates with 4% FCS to
inactivate trypsin and testing for inhibition of subsequent
CAT expression by the addition of monoclonal antibodies
P11 and P36, neutralizing antibodies specific for hPIV1
HN protein (Hetherington et al., 1994). For analysis of
intracellular CAT protein, transfected or virus-infected
FIG. 1. MDBK cells are not permissive for growth of hPIV1. LLC-MK2
cell monolayers were washed with PBS-A, collected by cells or MDBK cells were infected with hPIV1. Production of virus was
scraping, pelleted and suspended in 250 mM Tris, pH monitored as hemagglutinating units (HAU) at the indicated times after
infection.7.8, and lysed by three cycles of freeze/thawing. Lysates
were clarified by a 3000 g spin and supernates were
assayed for CAT enzyme activity (Gorman et al., 1982).
MDBK cells revealed no detectable cytopathic effects
(data not shown).Coculture of SV and hPIV1
SV and hPIV1 were grown together by coculturing in Viral gene expression in nonpermissive cells
LLC-MK2 cells permissive for both viruses. Stocks of
To examine an early step in virus replication, we askedeach virus were mixed at a titer of 0.1 hemagglutinating
if hPIV1 could mediate protein expression in a nonper-unit (HAU)/ml, and 0.5 ml of this mixture was inoculated
missive environment. Permissive or nonpermissive cellsonto each 9.6-cm2 well of a six-well culture dish. Infected
were infected with hPIV1, and total cell lysates or RNAcultures were washed with DME, fed DME containing
extracts were collected either immediately after infection0.03% BSA and 0.5 mg/ml acetylated trypsin, and incu-
or at daily intervals. Virus gene expression was moni-bated at 377. After 2 days the resulting cocultured virus
tored both by Western blotting to detect the intracellularmixture was collected and used to infect MDBK cells.
accumulation of viral proteins and by Northern blottingLLC-MK2-grown virus was diluted to 0.1 HAU/ml and 0.5
to detect viral mRNA species. Figure 2 shows that bothml was inoculated into each 9.6-cm2 well of a six-well
NP and HN genes are expressed in infected MDBK cells,dish of MDBK cells. Infected MDBK cells were washed
although at lower levels than observed in permissivewith DME, fed DME containing BSA and trypsin, and
LLC-MK2 cells. Protein levels remain below those foundincubated at 377 for 2 days. After MDBK passage, the
in permissive cells through 4 days postinfection (Fig. 2A).virus supernate was collected and reinfected onto fresh
We also metabolically radiolabeled hPIV1-infected MDBKLLC-MK2 cells. This LLC-MK2 culture was continuously
cells with [3H]leucine and immunoprecipitated with anti-radiolabeled with [3H]leucine to permit evaluation of the
NP antibodies: detection of radiolabeled NP confirmedhPIV1 component surviving MDBK negative selection.
that viral protein can be newly synthesized in nonpermis-
sive cells (data not shown). Our protein expression data
RESULTS
were supported by observations of mRNA expression in
hPIV1-infected cells: both NP-specific and HN-specificMDBK cells are nonpermissive for hPIV1
(/) sense RNA species were observed in infected MDBK
Cultured LLC-MK2 cells are fully permissive for the cells, although at levels below those observed in infected
replication of hPIV1 as well as for SV. MDBK cells are LLC-MK2 cells (Fig. 2B).
permissive for SV; to determine if MDBK cells could also
support the growth of hPIV1, we infected these cells and Rescue of synthetic genome analog RNA
monitored the production of virus by hemagglutination
assay. LLC-MK2 cells were used as a positive control. We next asked if hPIV1 proteins could encapsidate
and transcribe new RNA molecules. As a reporter weFigure 1 shows that no hemagglutinating activity accu-
mulated in the medium of hPIV1-infected MDBK cells, used SV-CAT RNA, transcribed in vitro from plasmid
pSend-CAT (Park et al., 1991). This RNA is a functionaldemonstrating that these cells do not support the growth
of hPIV1. Consistent with the failure to produce virus analog of SV genome RNA, with SV-specific sequences
at its 3* and 5* termini. The reporter is designed so thatparticles, microscopic examination of hPIV1-infected
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FIG. 2. hPIV1 gene expression in permissive or nonpermissive cells. Cultured cells were infected with hPIV1, and samples were collected
immediately after infection (lane 0) or after 377 incubation at daily intervals (lanes 1–4). (A) Infected-cell proteins were examined by washing cells
with PBS and lysing by direct addition of protein gel loading buffer containing SDS and b-mercaptoethanol. Samples were boiled and loaded to a
7.5% polyacrylamide–SDS gel. Wells contained 20 ml of infected LLC-MK2 lysates or 40 ml of infected MDBK cell lysates. Proteins were fractionated
and electroblotted onto nitrocellulose. Virus proteins were visualized with anti-NP monoclonal antibodies P27 and P40 or anti-HN monoclonal
antibody M9 and 125I-labeled second antibody. (B) Total RNA was extracted, fractionated in a formaldehyde-agarose gel, blotted to nitrocellulose,
and hybridized with a 32P-labeled (0) sense RNA probe specific for the NP or HN gene as indicated.
CAT enzyme activity is expressed only when virus-spe- with specific cis-acting nucleotides near the termini of
SV-specific RNA. The two steps of encapsidation andcific proteins encapsidate the (0) sense SV-CAT reporter
RNA and transcribe CAT mRNA from it. We expected that mRNA transcription from a SV-specific template both oc-
curred, at comparable efficiencies with either species ofhPIV1 proteins would be able to recognize a SV-specific
reporter RNA, since Curran and Kolakofsky (1991) have helper virus. Therefore we next asked if SV-CAT reporter
shown that hPIV1 can drive intracellular RNA replication
of a SV-derived defective-interfering genome RNA in per-
missive cells. SV-CAT RNA was transfected into LLC-
MK2 or MDBK cells. Helper virus consisted of SV or hPIV1
or a mixture of both viruses. Two days after transfection
cell lysates were collected and tested for CAT enzyme
activity. Figure 3 shows that either Sendai virus or hPIV1
can support the encapsidation and transcription of SV-
specific reporter RNA in either cell type. In addition, re-
porter transcription also takes place when both species
of helper virus are used together, indicating that these
viruses do not interfere with each other in the rescue of
SV-specific RNA. The hPIV1-driven expression of CAT in
MDBK cells shows that the nucleocapsid proteins are
functional in these nonpermissive cells. Further, the ob-
servation of hPIV1-driven CAT expression levels compa-
FIG. 3. hPIV1 drives transcription from SV RNA analog. Cultured cellsrable to those observed with SV helper suggests that
were transfected with SV-CAT RNA and infected with the indicatedvery early events in infection, such as defective virus
helper viruses. After 2 days, transfected cells were harvested and cellattachment or penetration, are not responsible for the
lysates were tested for CAT enzyme activity. Phosphorimager quantita-
block to hPIV1 replication in MDBK cells. tion showed percentage chloramphenicol acetylated to be 40, 33, 54,
CAT activity shown in Fig. 3 confirms that hPIV1 nu- and 0%, reading left to right in the MDBK panel, and 97, 96, 78, and
0%, reading left to right in the LLC-MK2 panel.cleocapsid proteins are able to recognize and interact
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Viral RNA synthesis in nonpermissive cells
Since hPIV1 can synthesize viral proteins in nonper-
missive cells but cannot rescue and package a synthetic
SV-specific reporter RNA, a probable explanation was
that hPIV1 was unable to mediate any genome RNA repli-
cation in nonpermissive cells. To test this we next asked
if replication of the hPIV1 genome itself could take place.
To determine if full-length viral genome RNA was synthe-
sized in hPIV1-infected MDBK cells, we used Northern
blot analysis to examine cytoplasmic RNA from infected
cells. Negative-sense vRNA was detected with a mix of
radiolabeled RNA probes identical to SV and hPIV1 NP
mRNAs. Northern hybridization revealed a faint band in
hPIV1-infected MDBK cells 2 days after infection which
comigrated with full-length vRNA (Fig. 5A, lane 1). This
band was no longer detected 4 days after infection (Fig.
5A, lane 2). Positive control RNA samples extracted from
hPIV1-infected LLC-MK2 cells (Fig. 5A, lanes 3–4) or from
SV-infected cells (Fig. 5A, lanes 5 and 6), also revealed
hybridized bands of full-length vRNA.
A similar Northern blot procedure examined the accu-
mulation of (/) sense antigenome RNA molecules. In
this case the probe was a mixture of 32P-labeled in vitro
transcripts of reverse-oriented SV and hPIV1 NP genes.
These negative-sense probes hybridized to (/) sense
FIG. 4. SV-specific RNA analog is packaged into infectious particles.
(A) SV-CAT RNA was transfected into LLC-MK2 or MDBK cells and
rescued with SV or with hPIV1 helper virus as described in the legend
of Fig. 3. The combination of cell type and helper virus used in the
initial RNA rescue is indicated by the (//0) symbols in the center.
After 2 days, virus-containing supernate from each rescue culture was
treated with trypsin and serially passaged in fresh LLC-MK2 cells. In-
fected LLC-MK2 lysates were assayed for CAT activity after one or two
passages. (B) To confirm that infectious CAT-expressing material was
packaged into virus particles, supernate from the hPIV1 helper/LLC-
MK2 sample in (A) was treated in turn with trypsin and fetal calf serum
(lane 0) and then also treated with neutralizing monoclonal antibodies
to hPIV1 HN (lane /). Treated supernates were then inoculated onto
fresh cells for CAT assay as in (A).
RNA could be packaged into infectious material by hPIV1
and transmitted to fresh cells. The RNA transfection/virus
rescue experiment was repeated, and virus-containing
culture supernates were treated with trypsin and serially
passed through fresh LLC-MK2 cultures. Figure 4A shows
the CAT enzyme activity in cell lysates collected after
one or two passages in LLC-MK2 cells. The expression
of CAT activity after serial passage indicates that SV-CAT
RNA was packaged into infectious pseudovirus particles.
Either SV or hPIV1 helper was able to rescue infectious
SV-CAT pseudovirus when the initial RNA rescue was
done in LLC-MK2 cells. In contrast, hPIV1 could not prop- FIG. 5. hPIV1 vRNA accumulation in permissive or nonpermissive
cells. Intracellular vRNA was analyzed by Northern blotting. (A) Theagate detectable amounts of SV-CAT pseudovirus when
hybridization probe consisted of 32P-labeled (/) sense SV and hPIV1the initial RNA rescue was done in MDBK cells. Figure 4B
NP transcripts synthesized in vitro with T7 RNA polymerase. This probeshows that infectivity of the hPIV1-rescued CAT activity is
mixture detected (0) sense vRNA. (B) The hybridization probe was (0)
sensitive to anti-hPIV1 neutralizing antibody, confirming sense transcripts synthesized by T7 polymerase from reverse-oriented
that the rescued SV-CAT RNA was packaged into virus- SV and hPIV1 NP inserts. This probe detected (/) sense antigenome
RNA as well as NP-specific mRNA.like particles by hPIV1.
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antigenome RNA as well as to NP-specific mRNA. This
blot (Fig. 5B) revealed no antigenome RNA in hPIV1-
infected MDBK cells. This shows that no replicative RNA
synthesis had taken place and indicates that the faint
band of (0) sense 15-kb RNA (Fig. 5A, lane 1) repre-
sented genome RNA of the infecting virus inoculum. The
smaller molecular weight material in Fig. 5A was there-
fore probably due to degradation of inoculum virus ge-
nomes rather than to abortive vRNA synthesis since no
template for vRNA synthesis can be detected. The (0)
probe in Fig. 5B did reveal abundant NP-specific mRNA,
confirming that viral transcription takes place in these
nonpermissive cells.
We also examined genome replication by asking if
new nucleocapsid complexes could assemble within the
cytoplasm of infected cells, and perhaps be released as
enveloped particles. Figure 1 already showed that no
completely assembled hemagglutinating virus particles
were produced during hPIV1 infection of MDBK cells, but
it was still possible that nucleocapsids could be released FIG. 6. hPIV1 nucleocapsid accumulation in permissive or nonper-
missive cells. Cultured cells were infected with hPIV1 and continuouslyfrom infected cells within defective particles incapable
radiolabeled with [3H]leucine. After 1 or 2 days intracellular nucleocap-of agglutinating erythrocytes. Similarly, Fig. 5 already
sids (left) and virus released into the culture medium (right) were col-showed that no replicative synthesis of 15-kb genome
lected. Samples were fractionated in a polyacrylamide–SDS gel and
RNA took place in MDBK cells. It was still possible, how- visualized by fluorography.
ever, that subgenomic fragments of vRNA not detectable
in the Northern blot could become encapsidated. There-
fore to test for nucleocapsid assembly we looked both viruses of each strain were grown together through two
passages in LLC-MK2 cells and then passaged once inin the medium of hPIV1-infected cells and within the in-
fected cell lysates. Permissive or nonpermissive cells MDBK cells. After one MDBK passage the virus mixture
was grown again in LLC-MK2 cells, with radiolabel, towere hPIV1-infected and continuously radiolabeled with
[3H]leucine. At daily intervals intracellular nucleocapsid amplify any surviving hPIV1 to detectable levels. Radiola-
beled virus was pelleted from the LLC-MK2 culture me-complexes (Fig. 6, left panel) and virus particles released
into the culture medium (Fig. 6, right panel) were col- dium, and viral proteins were visualized by fluorography
to compare SV and hPIV1 components. The nucleopro-lected and their proteins fractionated in polyacrylamide–
SDS gels. Infection of LLC-MK2 cells resulted in abun- teins of these viruses can be easily distinguished by their
electrophoretic mobilities: SV NP migrates more slowlydant accumulation of intracellular complexes and of nu-
cleocapsids in released virus particles. In contrast, in- than that of hPIV1. Figure 7 shows that both species of
NP were present in the virus mixture after coculturing infected MDBK cells reveal no nucleocapsid complexes,
either in the cytoplasmic extract or in dense particles LLC-MK2 , confirming that the proteins and genome RNAs
of SV and hPIV1 were both present in the starting virusreleased into the culture medium. This suggests that if
molecules of vRNA (or any subgenomic fragments) are mixture. After a single round of MDBK selection the virus
population lost the ability to encode detectable hPIV1-synthesized, their encapsidation into stable nucleocap-
sid complexes is defective in MDBK cells. specific NP, indicating that hPIV1 genomes were still
unable to replicate in nonpermissive MDBK cells, even
in the presence of SV proteins. HPIV1 NP remained unde-Functional interactions between parainfluenza virus
tectable in the MDBK-selected material, even after multi-strains
ple subsequent passages in LLC-MK2 (data not shown).
We also asked if SV-CAT RNA, rescued by hPIV1 pro-The ability of hPIV1 to support the replication of SV-
CAT RNA shows that in permissive cells hPIV1 proteins teins in LLC-MK2 cells, could in turn be rescued by SV
in MDBK cells. It has been established that hPIV1 pro-can effectively substitute for SV proteins to encapsidate,
transcribe, replicate, and package a SV-specific RNA teins can functionally interact with an SV-specific RNA;
this experiment also addresses the question of whethermolecule. We wanted to further examine if heterologous
protein–protein interactions could also occur with a simi- SV proteins can interact with a ribonucleoprotein com-
plex comprising SV-specific RNA and hPIV1-specific pro-lar efficiency. We first asked if SV, capable of replication
in MDBK cells, could complement the replication of hPIV1 teins. We examined intracellular CAT activity when an
inoculum consisting of SV-CAT RNA rescued by hPIV1-which normally does not grow in these cells. Wild-type
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Such increased attenuation has been observed in non-
productive infections with viruses such as measles,
where the level of nucleoprotein expression is near nor-
mal but the expression levels for downstream viral genes
are greatly reduced (Cattaneo et al., 1987; Schneider-
Schaulies et al., 1989). To test this possibility, we exam-
ined expression levels of hPIV1 NP as well as a down-
stream gene, HN. While expression of both genes was
reduced relative to the levels observed in permissive
cells, NP and HN expression were reduced by compara-
ble amounts. If increased attenuation were responsible
FIG. 7. SV does not complement hPIV1 replication in MDBK cells. for nonpermissivity, we would expect HN expression to
SV and hPIV1 were cultured together in coinfected LLC-MK2 cells. The be reduced by a much greater factor than NP expression.
resulting virus mixture was then passaged through MDBK cells. After
Since expression for each gene was reduced in MDBKMDBK passage, surviving hPIV1 content of the culture supernate was
cells by a similar amount relative to LLC-MK2 levels, wedetermined by infecting fresh LLC-MK2 cells and radiolabeling with
[3H]leucine. Virus was pelleted from LLC-MK2 culture supernates and conclude that increased attenuation does not play a role
disrupted with SDS. Viral proteins were fractionated in a polyacryl- in hPIV1 infection of MDBK cells.
amide–SDS gel and visualized by fluorography. Lanes labeled MK2 What then is the molecular basis for the host-range
contain LLC-MK2-grown SV or hPIV1 or a cocultured mixture of both restriction of hPIV1 growth in MDBK cells? Our data sug-viruses. The lane labeled after MDBK selection contains material from
gest it is probably not related to cell receptor affinity orthe cocultured virus mixture passaged once through MDBK cells and
then radiolabeled in LLC-MK2 cells. availability, or to other issues involved in virus entry into
the cell, since hPIV1 can encapsidate transfected SV-
CAT RNA in MDBK cells at an efficiency comparable to
in LLC-MK2 cells was used to infect fresh MDBK cells, that observed with SV helper virus. We have directly
either without or with coinfecting SV. Trace CAT activity
shown that hPIV1 NP and HN proteins are synthesized
was detected, but disappeared after an additional MDBK
in MDBK cells, and the observation that CAT mRNA is
passage of the trypsin-treated MDBK supernates (data
transcribed during hPIV1 rescue in these cells also indi-
not shown). This experiment confirmed that hPIV1-encap-
cates that hPIV1 P and L proteins are functional. Growth
sidated SV-CAT RNA could not be efficiently replicated
restriction evidently reflects impaired vRNA synthesis
by SV proteins.
and/or nucleocapsid assembly since neither nucleocap-
sid complexes nor full-length cRNA are observed. Since
DISCUSSION
we have not directly tested each step in the infectious
process which must precede genome replication, theOne consequence of the complex nature of virus–host
interactions is that cells derived from similar tissues in possibility remains that other specific steps associated
with early events in hPIV1 infection may be partially de-different host species can vary widely in their ability to
support virus replication. The phenomenon of host range fective in MDBK cells; however, the simplest explanation
of our data is that virus genome replication is blocked.restriction can help to illuminate slight differences in the
biochemical environment within each type of cell and so Whether the failure to accumulate ribonucleoprotein
complexes is a cause or an effect of defective vRNAreveal points where the virus relies on host cell compo-
nents to assist in the virus replication cycle. Our studies synthesis cannot yet be determined with certainty, but
our data imply that the RNA encapsidation process mighton host range restriction of hPIV1 replication in MDBK
have provided some fundamental information about the proceed normally since SV-CAT RNA can be incorpo-
rated into a functional transcription template. Expressionnature of cellular permissivity for virus replication, as well
as helping to demonstrate the extent to which compo- of CAT mRNA in nonpermissive cells shows that NP, P,
and L proteins can function to encapsidate and tran-nents of one parainfluenza strain can functionally substi-
tute for components of a related strain. Curran and Kola- scribe SV-specific RNA.
When heterologous nucleocapsids comprising SV-kofsky (1991) previously showed that hPIV1 can drive the
intracellular replication of SV-specific RNA species. We specific RNA and hPIV1 proteins were packaged in per-
missive cells and then passaged into MDBK cells, SVhave extended those findings by showing that hPIV1 can
rescue SV-specific RNA into a functional transcription helper virus proteins were unable to drive their replica-
tion. Similarly SV was unable to complement the growthtemplate in nonpermissive cells and into packaged infec-
tious particles in permissive cells. of hPIV1 in MDBK cells coinfected with both viruses.
These results support the idea that host range restrictionWhen trying to determine the molecular basis for re-
striction of hPIV1 growth, it was important to consider occurs at a point following RNA encapsidation by NP.
Inhibition of hPIV1 vRNA replication might occur at thethe possibility that the program of viral gene expression
was more steeply attenuated in nonpermissive cells. steps of strand initiation or elongation. It is also possible
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that the reduced amount of hPIV1 protein expression of several points depending on the particular combina-
tion of virus and nonpermissive cell.observed in MDBK cells results in failure to accumulate
sufficient soluble nucleoprotein to effect the switch from
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